NCT03778359 - Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis | Biotech Hunter

Enrollment

5,000

Participants

Timeline

Start Date

January 1, 2005

Primary Completion Date

December 31, 2015

Study Completion Date

October 18, 2018

Conditions

EndometriosisAdenomyosis

Interventions

DRUG

Leuprorelin

This study was designed to analyze the differences in prognosis and recurrence of patients with endometriosis and adenomyosis after receiving various surgical and medical treatments. This arm intervention is Leuprorelin.

DEVICE

Levonorgestrel

This study was designed to analyze the differences in prognosis and recurrence of patients with endometriosis and adenomyosis after receiving various surgical and medical treatments. This arm intervention is Levonorgestrel.

DRUG

Dienogest

This study was designed to analyze the differences in prognosis and recurrence of patients with endometriosis and adenomyosis after receiving various surgical and medical treatments. This arm intervention is Dienogest.

DRUG

Progestins

This study was designed to analyze the differences in prognosis and recurrence of patients with endometriosis and adenomyosis after receiving various surgical and medical treatments. This arm intervention is Progestins.

Trial Locations (1)

112

Peng-Hui Wang, Taipei County